+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Enzymes Global Market Report 2020-30: COVID-19 Growth and Change

  • ID: 5230025
  • Report
  • December 2020
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Allergan plc
  • Codexis Inc
  • Digestive Care
  • Horizon Pharma
  • Leadiant Biosciences
  • MORE
Enzymes Global Market Report 2020-30: Healthcare Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global enzymes market.

This report focuses on enzymes market which is experiencing strong growth. The report gives a guide to the enzymes market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the enzymes? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Enzymes market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider enzymes market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The enzymes market section of the report gives context. It compares the enzymes market with other segments of the enzymes market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, enzymes indicators comparison.
Scope

Markets Covered:
1) By Product Type: Asparaginase; Lipase; Protease; Nattokinase; Chitinase; Serratiopeptidase; Collagenase; Ligase; Others
2) By Application: Leukemia; Stomach Disorders; Antitumor; Skin Ulcers; Gaucher Disease; Fabry Disease; Others

Companies Mentioned: Sanofi; AbbVie Inc.; Alexion Pharmaceuticals Inc; Horizon Pharma; Allergan plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Allergan plc
  • Codexis Inc
  • Digestive Care
  • Horizon Pharma
  • Leadiant Biosciences
  • MORE
1. Executive Summary

2. Enzymes Market Characteristics

3. Enzymes Market Size and Growth
3.1. Global Enzymes Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers of the Market
3.1.2. Restraints on the Market
3.2. Global Enzymes Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers of the Market
3.2.2. Restraints on the Market

4. Enzymes Market Segmentation
4.1. Global Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Asparaginase
  • Lipase
  • Protease
  • Nattokinase
  • Chitinase
  • Serratiopeptidase
  • Collagenase
  • Ligase
  • Others
4.2. Global Enzymes Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Leukemia
  • Stomach Disorders
  • Antitumor
  • Skin Ulcers
  • Gaucher Disease
  • Fabry Disease
  • Others
5. Enzymes Market Regional and Country Analysis
5.1. Global Enzymes Market, Split by Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Enzymes Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Enzymes Market
6.1. Asia-Pacific Enzymes Market Overview
6.2. Asia-Pacific Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Enzymes Market
7.1. China Enzymes Market Overview
7.2. China Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Enzymes Market
8.1. India Enzymes Market Overview
8.2. India Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Enzymes Market
9.1. Japan Enzymes Market Overview
9.2. Japan Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Enzymes Market
10.1. Australia Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Enzymes Market
11.1. Indonesia Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Enzymes Market
12.1. South Korea Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Enzymes Market
13.1. Western Europe Enzymes Market Overview
13.2. Western Europe Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Enzymes Market
14.1. UK Enzymes Market Overview
14.2. UK Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Enzymes Market
15.1. Germany Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Enzymes Market
16.1. France Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Enzymes Market
17.1. Eastern Europe Enzymes Market Overview
17.2. Eastern Europe Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Enzymes Market
18.1. Russia Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Enzymes Market
19.1. North America Enzymes Market Overview
19.2. North America Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Enzymes Market
20.1. USA Enzymes Market Overview
20.2. USA Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Enzymes Market
21.1. South America Enzymes Market Overview
21.2. South America Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Enzymes Market
22.1. Brazil Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Enzymes Market
23.1. Middle East Enzymes Market Overview
23.2. Middle East Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Enzymes Market
24.1. Africa Enzymes Market Overview
24.2. Africa Enzymes Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Enzymes Market Competitive Landscape and Company Profiles
25.1. Enzymes Market Competitive Landscape
25.2. Enzymes Market Company Profiles
25.2.1. Sanofi
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. AbbVie Inc.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Alexion Pharmaceuticals Inc
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Horizon Pharma
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Allergan plc
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers and Acquisitions in the Enzymes Market

27. Enzymes Market Trends and Strategies

28. Enzymes Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Allergan plc
  • Codexis Inc
  • Digestive Care
  • Horizon Pharma
  • Leadiant Biosciences
  • MORE
Major players in the enzymes market are Sanofi, AbbVie Inc., Alexion Pharmaceuticals Inc, Horizon Pharma, Allergan plc, Pfizer Inc., Vivus, Digestive Care, Leadiant Biosciences and Roche Holdings AG.

The global enzymes market is expected to decline from $7.98 billion in 2019 to $7.81 billion in 2020 at a compound annual growth rate (CAGR) of -2.20%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $11.92 billion in 2023 at a CAGR of 15.15%.

The enzymes market consists of sales of enzymes to treat diseases. An enzyme is a protein or RNA formed by living cells that are extremely specific to its substrates and highly catalytic. Enzymes constitute a very significant class of biological macromolecular catalysts. Enzymes that are used in medical applications in their isolated or conjugated form with other drugs or therapies are known as therapeutic enzymes. Therapeutic enzymes are used in the treatment of various diseases including cancer, inflammatory disorders, cardiovascular diseases, and pain management.

North America was the largest region in the enzymes market in 2019.

In May 2020, AbbVie Inc., a US-based biopharmaceutical company, acquired Allergan plc for $63 billion. This acquisition significantly expands and diversifies AbbVie's revenue base and complements existing leadership positions in Immunology, with Humira and recently launched Skyrizi and Rinvoq, and Hematologic Oncology, with Imbruvica and Venclexta. Allergan plc is an Ireland-based pharmaceutical company engaged in the research, development, and manufacture of pharmaceutical and enzymes-based therapeutic products.

The enzymes market covered in this report is segmented by product type into asparaginase; lipase; protease; nattokinase; chitinase; serratiopeptidase; collagenase; ligase; others and by application into leukemia; stomach disorders; antitumor; skin ulcers; gaucher disease; fabry disease; others.

The development of new approaches to treat cancer using enzymes is a key trend gaining popularity in the enzymes market. Major universities and companies are investing in researches focusing on evolving new solutions in enzyme therapies for cancer treatment. For example, in August 2018, Kyn Therapeutics, a US-based company that focuses on improving outcomes for cancer patients, along with the Cancer Prevention and Research Institute of Texas and the American Cancer Society funded the research introducing a new approach to cancer care using enzyme therapy to boost the immune system and fight back. The enzyme, PEG-KYNase, does not destroy cancer cells specifically but rather enables the immune system itself to remove unwanted cells. PEG-KYNase is designed to degrade the metabolite produced by numerous tumors known as kynurenine, which suppresses the immune system.

The growing prevalence of cancer and the need for drug-metabolizing enzymes (DMEs) for chemotherapy are expected to drive the growth of the enzymes market in the coming years. The activation of enzymes in a human body help destroy the cancer cells and breaks down the tumor. The expression and function of DMEs in cancer patients' tumor tissues and metabolic organs is therefore essential and help patients for whom reaction to anticancer drugs and response to chemotherapy is low. According to the World Health Organization (WHO), 9.6 million deaths occurred in 2018 due to cancer and about 70% of deaths from cancer occur in low- and middle-income countries. Therefore, the increasing prevalence of cancer, which can be cured using therapeutic enzymes, is predicted to drive the growth of the enzymes market.
Note: Product cover images may vary from those shown
4 of 5
  • Sanofi
  • AbbVie Inc.
  • Alexion Pharmaceuticals Inc
  • Horizon Pharma
  • Allergan plc
  • Pfizer Inc.
  • Vivus
  • Digestive Care
  • Leadiant Biosciences
  • Roche Holdings AG
  • Codexis Inc
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll